What type of vaccine series is recommended for RotaTeq (RV5)?

The recommended vaccination schedule for RotaTeq (RV5) is indeed a 3-dose series. This vaccine is designed to protect against rotavirus gastroenteritis, which can lead to severe diarrhea and dehydration in infants and young children. The vaccination schedule typically involves administering the first dose at 2 months of age, followed by subsequent doses at 4 months and 6 months of age.

The 3-dose series is significant because it ensures adequate immunity is provided to children, maximizing their protection against the disease. Each dose is important for building and strengthening the child’s immune response to the rotavirus. Adhering to this 3-dose schedule helps to minimize the risk of infection during the most vulnerable periods of early childhood development.

In contrast, the other options suggest different dosing strategies that do not align with the current guidelines for RotaTeq. A 2-dose series may not provide enough immunity, while a 1-dose or 4-dose series is inconsistent with the established recommendations for this particular vaccine.